Surgical Outcomes During COVID-19 Pandemic
| Autor: | Carlos Yoldi-Aguirre, Indira Morales Garcia, Andrea Nachón-Acosta, Irais Olivares-Garcia, Gustavo Martínez-Mier, Victor Flores-Gamboa, Maritza De la Paz-Román, Octavio Avila-Mercado |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Male
0301 basic medicine medicine.medical_specialty Complications Multivariate analysis medicine.medical_treatment Outcomes Article Sepsis 03 medical and health sciences Postoperative Complications 0302 clinical medicine Surgical oncology Pandemic medicine Humans Mortality Mexico Dialysis Cross Infection Univariate analysis SARS-CoV-2 business.industry COVID-19 General Medicine Middle Aged medicine.disease Surgery Coronavirus Hospitalization 030104 developmental biology Surgical Procedures Operative 030220 oncology & carcinogenesis Female Observational study Morbidity business Complication |
| Zdroj: | Archives of Medical Research |
| ISSN: | 0188-4409 |
| DOI: | 10.1016/j.arcmed.2021.01.003 |
| Popis: | Highlights • Patients undergoing surgery are a vulnerable risk of COVID-19 exposure/infection. • There was a 79% decrease in the surgical activity (general surgery and oncological surgery) • Postoperative morbidity and mortality in COVID-19 patients is high. Background In December 2019, an outbreak of a novel coronavirus (COVID-19) occurred in China and became pandemic in March 2020. Patients undergoing surgery are a vulnerable risk of COVID-19 exposure/infection. The aim of the study was to determine the characteristics and outcomes of patients undergoing surgery during the COVID-19 pandemic in a third level reference hospital in Mexico. Method IRB approved observational study (prospectively collected database) of general and surgical oncology procedures from 04/20–08/20. Patients preoperative data and surgical cases registered. COVID-19 detection was a combination of polymerase chain reaction swab and chest computed tomography. Primary endpoints were: 30 d surgical mortality and complications, including COVID-19 infection during hospitalization. Results 193 patients were included (mean age: 53.9 years, 63.7% female). 52.8% procedures were performed by surgical oncology. 42.4% developed a complication with 8.3% mortality. COVID-19 infection was 11.3% (n = 22). Postoperative morbidity (81.3 vs. 37.4%, p = 0.0001) and mortality (27.3 vs. 5.8%, p = 0.0001) was higher in COVID-19 (+) patients. Factors associated with COVID-19 infections were sex, functional status, preoperative sepsis and ventilation, renal failure and dialysis (univariate analysis) and sepsis and renal failure (multivariate analysis). COVID-19 infection was associated with respiratory complications (54.5 vs. 2.9%), surgical site infection (27.3 vs. 10.5%), postoperative transfusions (59.1 vs. 31.6%), renal failure (54.5 vs. 8.2%), sepsis (68.2 vs. 22.2%), reintervention (22.7 vs. 7.6%), readmission (18.2 vs. 4.1%), and death (27.3 vs. 5.8%) (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect